AI assistant
CORCEPT THERAPEUTICS INC — Director's Dealing 2016
Nov 15, 2016
30681_dirs_2016-11-14_0bb52e01-77ce-4871-8af2-39495a3d3e32.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-11-10
Reporting Person: BELANOFF JOSEPH K (Director, CHIEF EXECUTIVE OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-10 | Common Stock | M | 300000 | $1.50 | Acquired | 2464195 | Direct |
| 2016-11-10 | Common Stock | S | 300000 | $8.9015 | Disposed | 2164195 | Direct |
| 2016-11-11 | Common Stock | M | 200000 | $1.50 | Acquired | 2364195 | Direct |
| 2016-11-11 | Common Stock | S | 200000 | $9.1015 | Disposed | 2164195 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-10 | Stock Option (Right to Buy) | $1.50 | M | 300000 | Disposed | 2017-04-16 | Common Stock (300000) | Direct |
| 2016-11-11 | Stock Option (Right to Buy) | $1.50 | M | 200000 | Disposed | 2017-04-16 | Common Stock (200000) | Direct |
Footnotes
F1: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.86 to $9.039 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.
F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.91 to $9.36 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.
F3: Fully exercisable.